Detalhe da pesquisa
1.
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Mol Ther
; 31(11): 3322-3336, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689971
2.
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19.
PLoS Pathog
; 17(8): e1009758, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379705
3.
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
J Biomed Sci
; 29(1): 49, 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35799178
4.
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Emerg Microbes Infect
; 12(1): 2149353, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395071